Asia Pacific Antibiotics & Antimycotics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

No. of Pages: 191    |    Report Code: BMIRE00032106    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Antibiotics & Antimycotics Market

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:

3.2.2 Macroeconomic factor analysis:

3.2.3 Developing base number:

3.2.4 Data Triangulation:

3.2.5 Country-level data:

4. Asia Pacific Antibiotics and Antimycotics Market - Key Market Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Infectious Diseases

4.1.2 Growing Awareness About Fungal Infections

4.2 Market Restraints

4.2.1 Antimicrobial Resistance, Financial Barriers, and Extensive Regulatory Processes

4.3 Market Opportunities

4.3.1 Ongoing Funding and Research & Development Initiatives

4.4 Future Trends

4.4.1 Technological Advancements in Product Development and Treatment Delivery Approaches

4.5 Impact of Drivers and Restraints:

5. Antibiotics and Antimycotics Market - Asia Pacific Analysis

5.1 Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031

5.2 Asia Pacific Antibiotics and Antimycotics Market Forecast Analysis

6. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Drug Class

6.1 Penicillin

6.1.1 Overview

6.1.2 Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.2 Cephalosporines

6.2.1 Overview

6.2.2 Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.3 Carbapenems

6.3.1 Overview

6.3.2 Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.4 Macrolides

6.4.1 Overview

6.4.2 Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.5 Aminoglycosides

6.5.1 Overview

6.5.2 Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.6 Quinolones

6.6.1 Overview

6.6.2 Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.7 Sulfonamides

6.7.1 Overview

6.7.2 Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.8 Tetracyclines

6.8.1 Overview

6.8.2 Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.9 Azoles

6.9.1 Overview

6.9.2 Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

6.10 Others

6.10.1 Overview

6.10.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Indication

7.1 Skin Infections

7.1.1 Overview

7.1.2 Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.2 Respiratory Infections

7.2.1 Overview

7.2.2 Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.3 Urinary Tract Infections (UTI)

7.3.1 Overview

7.3.2 Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.4 Septicemia

7.4.1 Overview

7.4.2 Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.5 Ear Infections

7.5.1 Overview

7.5.2 Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.6 Gastrointestinal Infections

7.6.1 Overview

7.6.2 Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Route of Administration

8.1 Oral

8.1.1 Overview

8.1.2 Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.2 Topical

8.2.1 Overview

8.2.2 Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

8.3 Others

8.3.1 Overview

8.3.2 Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Antibiotics and Antimycotics Market Analysis - by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview

9.1.2 Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.2 Retail Pharmacies

9.2.1 Overview

9.2.2 Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

9.3 Online Pharmacies

9.3.1 Overview

9.3.2 Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Antibiotics and Antimycotics Market - Country Analysis

10.1 Asia Pacific

10.1.1 Asia Pacific Antibiotics and Antimycotics Market Overview

10.1.2 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country

10.1.2.1 Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast Analysis - by Country

10.1.2.2 China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.2.2.1 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class

10.1.2.2.2 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication

10.1.2.2.3 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration

10.1.2.2.4 China: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel

10.1.2.3 Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.2.3.1 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class

10.1.2.3.2 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication

10.1.2.3.3 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration

10.1.2.3.4 Japan: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel

10.1.2.4 India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.2.4.1 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class

10.1.2.4.2 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication

10.1.2.4.3 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration

10.1.2.4.4 India: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel

10.1.2.5 Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.2.5.1 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class

10.1.2.5.2 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication

10.1.2.5.3 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration

10.1.2.5.4 Australia: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel

10.1.2.6 South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.2.6.1 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class

10.1.2.6.2 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication

10.1.2.6.3 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration

10.1.2.6.4 South Korea: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel

10.1.2.7 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

10.1.2.7.1 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Drug Class

10.1.2.7.2 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Indication

10.1.2.7.3 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Route of Administration

10.1.2.7.4 Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market Share - by Distribution Channel

11. Antibiotics and Antimycotics Market - Industry Landscape

11.1 Overview

11.2 Growth Strategies in Antibiotics and Antimycotics Market

11.3 Organic Growth Strategies

11.3.1 Overview

11.4 Inorganic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Pfizer Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Novartis AG

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Sanofi SA

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 F. Hoffmann-La Roche Ltd

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Merck & Co Inc

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 GSK Plc

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Johnson & Johnson

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Cipla Ltd

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Bayer AG

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 AbbVie Inc

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

12.11 Astellas Pharma Inc

12.11.1 Key Facts

12.11.2 Business Description

12.11.3 Products and Services

12.11.4 Financial Overview

12.11.5 SWOT Analysis

12.11.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

List of Tables

Table 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation

Table 2. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Table 3. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Drug Class

Table 4. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Indication

Table 5. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Route of Administration

Table 6. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Distribution Channel

Table 7. Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country

Table 8. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class

Table 9. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication

Table 10. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration

Table 11. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel

Table 12. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class

Table 13. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication

Table 14. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration

Table 15. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel

Table 16. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class

Table 17. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication

Table 18. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration

Table 19. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel

Table 20. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class

Table 21. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication

Table 22. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration

Table 23. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel

Table 24. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class

Table 25. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication

Table 26. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration

Table 27. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel

Table 28. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Drug Class

Table 29. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication

Table 30. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Route of Administration

Table 31. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Distribution Channel

Table 32. Recent Organic Growth Strategies in Antibiotics and Antimycotics Market

Table 33. Recent Inorganic Growth Strategies in the Antibiotics and Antimycotics Market

Table 34. Glossary of Terms, Antibiotics and Antimycotics Market

List of Figures

Figure 1. Asia Pacific Antibiotics and Antimycotics Market Segmentation - Country

Figure 2. Asia Pacific Antibiotics and Antimycotics Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Asia Pacific Antibiotics and Antimycotics Market Revenue (US$ Million), 2021-2031

Figure 5. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Drug Class (2023 and 2031)

Figure 6. Penicillin: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 7. Cephalosporines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 8. Carbapenems: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 9. Macrolides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 10. Aminoglycosides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 11. Quinolones: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 12. Sulfonamides: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 13. Tetracyclines: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 14. Azoles: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 15. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 16. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Indication (2023 and 2031)

Figure 17. Skin Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 18. Respiratory Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 19. Urinary Tract Infections (UTI): Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 20. Septicemia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 21. Ear Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 22. Gastrointestinal Infections: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 23. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 24. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Route of Administration (2023 and 2031)

Figure 25. Oral: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 26. Topical: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 27. Others: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 28. Asia Pacific Antibiotics and Antimycotics Market Share (%) - by Distribution Channel (2023 and 2031)

Figure 29. Hospital Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 30. Retail Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 31. Online Pharmacies: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021-2031 (US$ Million)

Figure 32. Asia Pacific Antibiotics and Antimycotics Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 33. China: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 34. Japan: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 35. India: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 36. Australia: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 37. South Korea: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 38. Rest of APAC: Asia Pacific Antibiotics and Antimycotics Market - Revenue and Forecast, 2021- 2031 (US$ Million)

Figure 39. Growth Strategies in Antibiotics and Antimycotics Market

The List of Companies - Asia Pacific Antibiotics & Antimycotics Market

  • Pfizer Inc
  • Novartis AG
  • Sanofi SA
  • F. Hoffmann-La Roche Ltd
  • Merck & Co Inc
  • GSK Plc
  • Johnson & Johnson
  • Cipla Ltd
  • Bayer AG
  • AbbVie Inc
  • Astellas Pharma Inc